Innomorph Drugs Private Limited
About Innomorph Drugs Private Limited
Data last updated:
Innomorph Drugs Private Limited was a private limited company based in Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the speciality chemicals segment of the chemicals sector. It was incorporated on 11 November 2004.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PTC044602.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Pavani Bommareddy and Venkatram Reddy Pulagam.
Its last annual general meeting (AGM) was held on 28 April 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at 6 – 3 – 883/5. Venkat Plaza.Punjagutta Hyderabad 082 Punjagutta Hyderabad 082, Telangana, India.
Company details
CIN history
Innomorph Drugs has one previous CIN (Corporate Identification Number): U24239AP2004PTC044602. The current CIN is U24239TG2004PTC044602, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PTC044602 | Current |
| U24239AP2004PTC044602 | Previous |
Contact details
Innomorph Drugs Private Limited's registered office is in Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address6 – 3 – 883/5. Venkat Plaza.Punjagutta Hyderabad 082 Punjagutta Hyderabad 082, Telangana, India
- IndustryChemicals, Other Chemical Product, Manufacturing
To see the full contact details of Innomorph Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Innomorph Drugs Private Limited
FY 2018 filings availableFinancial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Innomorph Drugs Private Limited, buy the company report.
Board of directors of Innomorph Drugs Private Limited
Innomorph Drugs has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pavani Bommareddy | Director | 11 Nov 2004 | 21 Years 11 Months | As last reported |
| Venkatram Reddy Pulagam | Director | 01 Aug 2011 | 15 Years 2 Months | As last reported |
| Veera Venkata Siva Kumar Reddy Bommareddy | Director | 11 Nov 2004 | 21 Years 11 Months | As last reported |
Auditor
Innomorph Drugs Private Limited is audited by AMAR & RAJU for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMAR & RAJU | FY 2018 | 000092S |
Shareholding
The shareholding of Innomorph Drugs Private Limited is on record for 4 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Innomorph Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Innomorph Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Innomorph Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Innomorph Drugs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Innomorph Drugs Private Limited has 3 board changes on record since 2004: 3 appointments. The latest: Venkatram Reddy Pulagam was appointed as Director on 01 Aug 2011.
Frequently asked questions
Innomorph Drugs has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Innomorph Drugs was a private limited company based in Telangana, India. The company worked in other chemical product, within the chemicals industry. It was incorporated on 11 November 2004 and is registered under CIN U24239TG2004PTC044602. The company has been struck off by the Registrar of Companies and is no longer operational.
Innomorph Drugs had 3 directors:
- Pavani Bommareddy - Director
- Venkatram Reddy Pulagam - Director
- Veera Venkata Siva Kumar Reddy Bommareddy - Director
The CIN (Corporate Identification Number) of Innomorph Drugs is U24239TG2004PTC044602. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Innomorph Drugs is at 6 – 3 – 8835. Venkat Plaza.Punjagutta Hyderabad 082 Punjagutta Hyderabad 082, Telangana, India.
Innomorph Drugs was incorporated on 11 November 2004. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Innomorph Drugs on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 28 April 2018. Year-wise statements from 2015 are in the company report.
Innomorph Drugs operated in the chemicals industry, in the other chemical product segment. It worked in this industry before it was struck off.
Venkatram Reddy Pulagam was appointed as Director on 01 Aug 2011. Pavani Bommareddy was appointed as Director on 11 Nov 2004. Veera Venkata Siva Kumar Reddy Bommareddy was appointed as Director on 11 Nov 2004.
Innomorph Drugs can be reached at its registered office: 6 – 3 – 8835. Venkat Plaza.Punjagutta Hyderabad 082 Punjagutta Hyderabad 082, Telangana, India.